These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
453 related articles for article (PubMed ID: 29504542)
1. Multimodal Neuroimaging in Alzheimer's Disease: Early Diagnosis, Physiopathological Mechanisms, and Impact of Lifestyle. Chételat G J Alzheimers Dis; 2018; 64(s1):S199-S211. PubMed ID: 29504542 [TBL] [Abstract][Full Text] [Related]
2. Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers. Chételat G; Fouquet M Rev Neurol (Paris); 2013 Oct; 169(10):729-36. PubMed ID: 24016463 [TBL] [Abstract][Full Text] [Related]
3. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials. Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ; Alzheimers Dement; 2017 Apr; 13(4):e1-e85. PubMed ID: 28342697 [TBL] [Abstract][Full Text] [Related]
4. Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease. Wang X; Huang W; Su L; Xing Y; Jessen F; Sun Y; Shu N; Han Y Mol Neurodegener; 2020 Sep; 15(1):55. PubMed ID: 32962744 [TBL] [Abstract][Full Text] [Related]
5. Early-Stage Identification and Pathological Development of Alzheimer's Disease Using Multimodal MRI. Yan T; Wang Y; Weng Z; Du W; Liu T; Chen D; Li X; Wu J; Han Y J Alzheimers Dis; 2019; 68(3):1013-1027. PubMed ID: 30958352 [TBL] [Abstract][Full Text] [Related]
6. Identification of Earlier Biomarkers for Alzheimer's Disease: A Multimodal Neuroimaging Study of Individuals with Subjective Cognitive Decline. Parker AF; Smart CM; Scarapicchia V; Gawryluk JR; J Alzheimers Dis; 2020; 77(3):1067-1076. PubMed ID: 32804127 [TBL] [Abstract][Full Text] [Related]
7. The Brain's Structural Connectome Mediates the Relationship between Regional Neuroimaging Biomarkers in Alzheimer's Disease. Pandya S; Kuceyeski A; Raj A; J Alzheimers Dis; 2017; 55(4):1639-1657. PubMed ID: 27911289 [TBL] [Abstract][Full Text] [Related]
8. Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities. Parent MJ; Zimmer ER; Shin M; Kang MS; Fonov VS; Mathieu A; Aliaga A; Kostikov A; Do Carmo S; Dea D; Poirier J; Soucy JP; Gauthier S; Cuello AC; Rosa-Neto P J Neurosci; 2017 Dec; 37(50):12263-12271. PubMed ID: 29097597 [TBL] [Abstract][Full Text] [Related]
9. Secondary prevention of Alzheimer's dementia: neuroimaging contributions. Ten Kate M; Ingala S; Schwarz AJ; Fox NC; Chételat G; van Berckel BNM; Ewers M; Foley C; Gispert JD; Hill D; Irizarry MC; Lammertsma AA; Molinuevo JL; Ritchie C; Scheltens P; Schmidt ME; Visser PJ; Waldman A; Wardlaw J; Haller S; Barkhof F Alzheimers Res Ther; 2018 Oct; 10(1):112. PubMed ID: 30376881 [TBL] [Abstract][Full Text] [Related]
10. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum. Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT; Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664 [TBL] [Abstract][Full Text] [Related]
11. The Vascular Hypothesis of Alzheimer's Disease: A Key to Preclinical Prediction of Dementia Using Neuroimaging. de la Torre J J Alzheimers Dis; 2018; 63(1):35-52. PubMed ID: 29614675 [TBL] [Abstract][Full Text] [Related]
12. [Neuroimaging in Alzheimer's disease: a synthesis and a contribution to the understanding of physiopathological mechanisms]. Villain N; Chételat G; Desgranges B; Eustache F Biol Aujourdhui; 2010; 204(2):145-58. PubMed ID: 20950559 [TBL] [Abstract][Full Text] [Related]
13. A whole-brain computational modeling approach to explain the alterations in resting-state functional connectivity during progression of Alzheimer's disease. Demirtaş M; Falcon C; Tucholka A; Gispert JD; Molinuevo JL; Deco G Neuroimage Clin; 2017; 16():343-354. PubMed ID: 28861336 [TBL] [Abstract][Full Text] [Related]
16. AI for the prediction of early stages of Alzheimer's disease from neuroimaging biomarkers - A narrative review of a growing field. Rudroff T; Rainio O; Klén R Neurol Sci; 2024 Nov; 45(11):5117-5127. PubMed ID: 38866971 [TBL] [Abstract][Full Text] [Related]
17. Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts. Cao L; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Yu JT; Tan L; Oncotarget; 2016 Mar; 7(12):13319-27. PubMed ID: 26950278 [TBL] [Abstract][Full Text] [Related]
18. Multimodal Neuroimaging Feature Learning With Multimodal Stacked Deep Polynomial Networks for Diagnosis of Alzheimer's Disease. Shi J; Zheng X; Li Y; Zhang Q; Ying S IEEE J Biomed Health Inform; 2018 Jan; 22(1):173-183. PubMed ID: 28113353 [TBL] [Abstract][Full Text] [Related]
19. Applied multimodal diagnostics in a case of presenile dementia. Schönecker S; Brendel M; Huber M; Vollmar C; Huppertz HJ; Teipel S; Okamura N; Levin J; Rominger A; Danek A BMC Neurol; 2016 Aug; 16():131. PubMed ID: 27506761 [TBL] [Abstract][Full Text] [Related]
20. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review. Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]